본문으로 건너뛰기
← 뒤로

Hsp60-Bearing Exosomes in -Induced Gastric Tumorigenesis: A Pathomorphological and Therapeutical Overview.

Cells 2025 Vol.14(21)

Gratie MI, Manna OM, Accomando S, Tomasello G, Cappello F, Fucarino A

📝 환자 설명용 한 줄

Chronic infection with is the leading environmental cause of gastric carcinogenesis, yet the molecular pathways remain incompletely defined.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Gratie MI, Manna OM, et al. (2025). Hsp60-Bearing Exosomes in -Induced Gastric Tumorigenesis: A Pathomorphological and Therapeutical Overview.. Cells, 14(21). https://doi.org/10.3390/cells14211652
MLA Gratie MI, et al.. "Hsp60-Bearing Exosomes in -Induced Gastric Tumorigenesis: A Pathomorphological and Therapeutical Overview.." Cells, vol. 14, no. 21, 2025.
PMID 41227297

Abstract

Chronic infection with is the leading environmental cause of gastric carcinogenesis, yet the molecular pathways remain incompletely defined. This review links -derived outer membrane vesicles (OMVs) and host epithelial exosomes through their shared cargo of heat shock protein 60 (GroEL/Hsp60). We proposed the concept of the "muco-microbiotic layer" as a fifth, functionally distinct layer of the gastric wall, where bacterial and host extracellular vesicles (EVs) interact within the mucus-microbiota interface. In this compartment, OMVs carrying bacterial GroEL and exosomes containing human Hsp60 engage in bidirectional communication that may promote chronic inflammation and epithelial transformation, with putative participation of molecular mimicry. The high structural homology between microbial and human Hsp60 enables repeated immune exposure to trigger cross-reactive responses-potentially leading to autoimmune-driven tissue damage, immune tolerance, and immune evasion in pre-neoplastic lesions. This vesicular crosstalk aligns with the evolution from non-atrophic gastritis to atrophy, from intestinal metaplasia to dysplasia, and lastly adenocarcinoma. Therapeutically, targeting EV-mediated Hsp60/GroEL signaling might offer promising strategies: EV-based biomarkers for early detection, monoclonal antibodies against extracellular Hsp60/GroEL, modulation of vesicle release, and probiotic-derived nanovesicles to restore mucosal balance. Hence, recognizing the muco-microbiotic layer and its vesicle-mediated signaling provides a new framework for understanding the infection-inflammation-cancer axis and for developing diagnostic and therapeutic approaches in -associated gastric cancer.

MeSH Terms

Humans; Chaperonin 60; Helicobacter pylori; Stomach Neoplasms; Exosomes; Helicobacter Infections; Carcinogenesis; Animals